Clauses 5. 9 and 5.11 above shall immediately cease to apply for a country of the Territory if: (a) a generic version of the Product exhibiting pharmacokinetic profiles that are bioequivalent to the Product is launched in that country of the Territory; or (b) in respect of a particular country if the Distributor’s rights in that country become Semi-Exclusive.
Appears in 2 contracts
Sources: Exclusive Distribution Agreement (Horizon Pharma, Inc.), Exclusive Distribution Agreement (Horizon Pharma, Inc.)